NEW RAY MEDIC recommends implementing a capital restructuring
I'm PortAI, I can summarize articles.
NEW RAY MEDIC's board of directors recommends implementing a capital restructuring, including share consolidation, capital reduction, and share subdivision. The specific measures are: 1. Consolidate every 10 shares with a par value of HKD 0.05 into 1 share with a par value of HKD 0.50, and cancel fractional shares; 2. Reduce the par value from HKD 0.50 to HKD 0.01, and transfer the proceeds to the paid-in surplus account; 3. Subdivide the unissued consolidated shares into 50 shares with a par value of HKD 0.01 each. The restructuring will not affect the relative rights of shareholders
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments